🇨🇦 CHIMPANZEE ADENOVIRUS ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN in Canada

CHIMPANZEE ADENOVIRUS ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN (CHIMPANZEE ADENOVIRUS ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN) regulatory status in Canada.

Marketing authorisation

CHIMPANZEE ADENOVIRUS ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CHIMPANZEE ADENOVIRUS ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for CHIMPANZEE ADENOVIRUS ENCODING SARS-COV-2 SPIKE GLYCOPROTEIN in Canada?

Marketing authorisation holder not available in our data.